Logo
duda-wsm • Nov 06, 2024

Bertus Kemp Stipendium for Marten Hoeksema

Marten Hoeksema received a Bertus Kemp Stipendium from the "Genootschap ter bevordering van Natuur-, Genees- en Heelkunde". The aim is  to study kinase activity differences in macrophages activated with various cytokines. The grant will be used for this research as well as a work visit to the lab of collaborator dr. Emiel van der Vorst at the university of Aachen.

Bertus Kemp was a biochemist at the University of Amsterdam, who was well known for his work on the biochemistry of connective tissue. He held a keen interest in prolyl hydroxylases and ATP synthase and incorporated azido-labelled substrate analogues in his research.

The ‘Stipendium Bertus Kemp’ of € 20.000 is awarded to an early-stage scientist in The Netherlands working at a university or research institute in Amsterdam, who needs financial support to extend her/his network and initiate novel or strengthen existing (inter)national collaborations for future applications for consortium grants, all aimed at making new discoveries in the field of biochemistry.


Source: https://gngh.nl/beurzen-en-bijdragen/

Share this message

Latest news Medical Biochemistry Amsterdam

By duda-wsm 06 Nov, 2024
Marten Hoeksema received a Bertus Kemp Stipendium from the " Genootschap ter bevordering van Natuur-, Genees- en Heelkunde ". The aim is to study kinase activity differences in macrophages activated with various cytokines. The grant will be used for this research as well as a work visit to the lab of collaborator dr. Emiel van der Vorst at the university of Aachen.
By duda-wsm 05 Nov, 2024
On Friday, 1st of November, Sebastian Hendrix defended his PhD thesis cum laude describing his work on the role of SPRING in regulating the SREBP pathway and lipid metabolism. The work included in the thesis describes how SREBP is required to promote the maturation of S1P, a protease that is required for the first cleavage-activation event of SREBPs. When SPRING is absent, SREBP cleavage cannot occur and as a consequence the SREBP pathway cannot be activated. The thesis positions SPRING as a core component of the SREBP activation machinery, the only new determinant added in the last 2 decades.
Show More
Share by: